Cyclerion Therapeutics (CYCN) News Today $2.82 +0.11 (+4.06%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.87 +0.05 (+1.77%) As of 02/21/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Cyclerion Therapeutics files $25M mixed securities shelfFebruary 5, 2025 | markets.businessinsider.com3 US Penny Stocks With Market Caps Over $10M To ConsiderFebruary 5, 2025 | finance.yahoo.comLooking Into Cyclerion Therapeutics's Recent Short InterestJanuary 3, 2025 | benzinga.comCyclerion Therapeutics announces update on next stage of growthDecember 18, 2024 | markets.businessinsider.comCyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company GrowthDecember 17, 2024 | finance.yahoo.comCyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company GrowthDecember 17, 2024 | globenewswire.comCyclerion Therapeutics (NASDAQ:CYCN) Stock Quotes, Forecast and News SummaryNovember 16, 2024 | benzinga.comRegina Graul, Ph.D., Promoted to Chief Executive OfficerAugust 7, 2024 | globenewswire.comCYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024May 8, 2024 | investorplace.comSage Therapeutics Stock (NASDAQ:SAGE), Quotes and News SummaryApril 28, 2024 | benzinga.comCyclerion Therapeutics Inc Ordinary Shares CYCNApril 21, 2024 | morningstar.comCYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023April 5, 2024 | investorplace.comTrading was temporarily halted for "CYCN" at 01:04 PM with a stated reason of "LULD pause."April 4, 2024 | marketbeat.comCyclerion Therapeutics Inc (CYCN)March 6, 2024 | investing.comCyclerion Therapeutics, Inc. (CYCN)February 29, 2024 | uk.finance.yahoo.comTrading was temporarily halted for "CYCN" at 09:02 AM with a stated reason of "LULD pause."February 26, 2024 | marketbeat.comCyclerion Therapeutics Stock (NASDAQ:CYCN) Dividends: History, Yield and DatesFebruary 23, 2024 | benzinga.comTrading was temporarily halted for "CYCN" at 09:12 AM with a stated reason of "LULD pause."December 20, 2023 | marketbeat.comTrading was temporarily halted for "CYCN" at 10:12 AM with a stated reason of "LULD pause."December 19, 2023 | marketbeat.comCyclerion Therapeutics appoints Graul as PresidentDecember 4, 2023 | msn.comCyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge InnovatorNovember 30, 2023 | finance.yahoo.comCyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With LossesNovember 28, 2023 | finance.yahoo.comTisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion AssetsJuly 31, 2023 | finance.yahoo.comCYCN - Cyclerion Therapeutics, Inc.June 30, 2023 | ca.finance.yahoo.comCyclerion Therapeutics, Inc.: Cyclerion Regains Compliance with Nasdaq Minimum Bid Price RequirementJune 2, 2023 | finanznachrichten.deCyclerion Therapeutics in compliance with Nasdaq minimum bid price ruleJune 1, 2023 | msn.comTrading was temporarily halted for "CYCN" at 02:05 PM with a stated reason of "LULD pause."May 16, 2023 | marketbeat.comTrading was temporarily halted for "CYCN" at 02:05 PM with a stated reason of "LULD pause."May 16, 2023 | marketbeat.comTrading was temporarily halted for "CYCN" at 12:05 PM with a stated reason of "LULD pause."May 16, 2023 | marketbeat.comTrading was temporarily halted for "CYCN" at 12:05 PM with a stated reason of "LULD pause."May 16, 2023 | marketbeat.comCyclerion Therapeutics, Inc.: Cyclerion Announces Reverse Stock SplitMay 16, 2023 | finanznachrichten.deCyclerion announces 1 for 20 reverse stock splitMay 15, 2023 | msn.comCyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New InvestorsMay 12, 2023 | finance.yahoo.comCyclerion Therapeutics, Inc.: Cyclerion Announces Corporate Updates and Q1 2023 Financial ResultsMay 12, 2023 | finanznachrichten.deCyclerion Therapeutics down 6% on spin off agreementMay 12, 2023 | msn.comCyclerion Announces Corporate Updates and Q1 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comCyclerion Announces Definitive Agreement for Zagociguat and CY3018May 11, 2023 | finance.yahoo.comCyclerion Therapeutics, Inc.: Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment AgreementApril 3, 2023 | finanznachrichten.deCyclerion Gets FDA Orphan Designation for Zagociguat in Mitochondrial Diseases >CYCNMarch 27, 2023 | marketwatch.comCyclerion Therapeutics, Inc.: Cyclerion Reports Corporate Update and Full Year 2022 Financial ResultsMarch 23, 2023 | finanznachrichten.deCyclerion Reports Corporate Update and Full Year 2022 Financial ResultsMarch 22, 2023 | finance.yahoo.comWhy American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From YesterdayNovember 23, 2022 | msn.comCyclerion Shares Rise After Spurned Bid for AssetsNovember 22, 2022 | marketwatch.comCyclerion Rejects Unsolicited Proposal To Buy Its AssetsNovember 22, 2022 | markets.businessinsider.comCyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The CompanyNovember 22, 2022 | finance.yahoo.comCyclerion Therapeutics lays off nearly half of workforceOctober 7, 2022 | finance.yahoo.comCyclerion Therapeutics IncSeptember 9, 2022 | reuters.comCyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue EstimatesAugust 9, 2022 | finance.yahoo.comCyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial ResultsAugust 9, 2022 | finance.yahoo.comIs Cyclerion Therapeutics (NASDAQ:CYCN) In A Good Position To Invest In Growth?August 8, 2022 | finance.yahoo.com Get Cyclerion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter. Email Address CYCN Media Mentions By Week CYCN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCN News Sentiment▼0.000.60▲Average Medical News Sentiment CYCN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCN Articles This Week▼00▲CYCN Articles Average Week Get Cyclerion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBIO News Today VRCA News Today EQ News Today QTTB News Today BIVI News Today PLUR News Today BFRG News Today IXHL News Today RLYB News Today PMN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYCN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
